logo
Breadcrumbs Image

Transdermal Patch Market

Transdermal Patch Market

Global Transdermal Patch Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027


Date: Apr-2021 | Id: MACRC-64304 | Geographical Scope: Global | Publisher: Mnemonics Research

The global Transdermal Patch market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Rresearch newly published report.
 The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
 
 By Market Verdors:
 Hisamitsu Pharmaceutical
 GSK
 UCB Pharma
 Johnson & Johnson
 Teikoku Seiyaku
 Novartis
 Pfizer
 Nitto Denko
 Mylan
 Luye Pharma Group
 Lohmann Therapie-Systeme
 Teva Pharmaceutical
 Beijing Tide Pharmaceutical
 Mundipharma
 Dr Reddy’s Laboratories
 Bayer
 
 By Types:
 Methyl Salicylate-based Patch
 Rivastigmine Transdermal Patch
 Fentanyl Transdermal Patch
 Nicotine Transdermal Patch
 Estradiol Transdermal Patch
 Others
 
 By Applications:
 Relieve Pain
 Smoking Stopping
 Cardiovascular Diseases
 Menopausal Syndrome
 Others
 
 Key Indicators Analysed
 Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
 Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
 Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
 Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
 Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
 
 Key Reasons to Purchase
 To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
 Assess the production processes, major issues, and solutions to mitigate the development risk.
 To understand the most affecting driving and restraining forces in the market and its impact in the global market.
 Learn about the market strategies that are being adopted by leading respective organizations.
 To understand the future outlook and prospects for the market.
 Besides the standard structure reports, we also provide custom research according to specific requirements.

Get Started with Request an Overview
Get Started with Download Brochure
Get Started with Request Methodology
Get Started with Share Customization
Get Started with Submit RFP
1 Report Overview
 1.1 Study Scope and Definition
 1.2 Research Methodology
 1.2.1 Methodology/Research Approach
 1.2.2 Data Source
 1.3 Key Market Segments
 1.4 Players Covered: Ranking by Transdermal Patch Revenue
 1.5 Market Analysis by Type
 1.5.1 Global Transdermal Patch Market Size Growth Rate by Type: 2021 VS 2027
 1.5.2 Methyl Salicylate-based Patch
 1.5.3 Rivastigmine Transdermal Patch
 1.5.4 Fentanyl Transdermal Patch
 1.5.5 Nicotine Transdermal Patch
 1.5.6 Estradiol Transdermal Patch
 1.5.7 Others
 1.6 Market by Application
 1.6.1 Global Transdermal Patch Market Share by Application: 2022-2027
 1.6.2 Relieve Pain
 1.6.3 Smoking Stopping
 1.6.4 Cardiovascular Diseases
 1.6.5 Menopausal Syndrome
 1.6.6 Others
 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections
 1.7.2 Covid-19 Impact: Commodity Prices Indices
 1.7.3 Covid-19 Impact: Global Major Government Policy
 1.8 Study Objectives
 1.9 Years Considered
 2 Global Transdermal Patch Market Trends and Growth Strategy
 2.1 Market Top Trends
 2.2 Market Drivers
 2.3 Market Challenges
 2.4 Porter’s Five Forces Analysis
 2.5 Market Growth Strategy
 2.6 SWOT Analysis
 3 Global Transdermal Patch Market Players Profiles
 3.1 Hisamitsu Pharmaceutical
 3.1.1 Hisamitsu Pharmaceutical Company Profile
 3.1.2 Hisamitsu Pharmaceutical Transdermal Patch Product Specification
 3.1.3 Hisamitsu Pharmaceutical Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.2 GSK
 3.2.1 GSK Company Profile
 3.2.2 GSK Transdermal Patch Product Specification
 3.2.3 GSK Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.3 UCB Pharma
 3.3.1 UCB Pharma Company Profile
 3.3.2 UCB Pharma Transdermal Patch Product Specification
 3.3.3 UCB Pharma Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.4 Johnson & Johnson
 3.4.1 Johnson & Johnson Company Profile
 3.4.2 Johnson & Johnson Transdermal Patch Product Specification
 3.4.3 Johnson & Johnson Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.5 Teikoku Seiyaku
 3.5.1 Teikoku Seiyaku Company Profile
 3.5.2 Teikoku Seiyaku Transdermal Patch Product Specification
 3.5.3 Teikoku Seiyaku Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.6 Novartis
 3.6.1 Novartis Company Profile
 3.6.2 Novartis Transdermal Patch Product Specification
 3.6.3 Novartis Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.7 Pfizer
 3.7.1 Pfizer Company Profile
 3.7.2 Pfizer Transdermal Patch Product Specification
 3.7.3 Pfizer Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.8 Nitto Denko
 3.8.1 Nitto Denko Company Profile
 3.8.2 Nitto Denko Transdermal Patch Product Specification
 3.8.3 Nitto Denko Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.9 Mylan
 3.9.1 Mylan Company Profile
 3.9.2 Mylan Transdermal Patch Product Specification
 3.9.3 Mylan Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.10 Luye Pharma Group
 3.10.1 Luye Pharma Group Company Profile
 3.10.2 Luye Pharma Group Transdermal Patch Product Specification
 3.10.3 Luye Pharma Group Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.11 Lohmann Therapie-Systeme
 3.11.1 Lohmann Therapie-Systeme Company Profile
 3.11.2 Lohmann Therapie-Systeme Transdermal Patch Product Specification
 3.11.3 Lohmann Therapie-Systeme Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.12 Teva Pharmaceutical
 3.12.1 Teva Pharmaceutical Company Profile
 3.12.2 Teva Pharmaceutical Transdermal Patch Product Specification
 3.12.3 Teva Pharmaceutical Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.13 Beijing Tide Pharmaceutical
 3.13.1 Beijing Tide Pharmaceutical Company Profile
 3.13.2 Beijing Tide Pharmaceutical Transdermal Patch Product Specification
 3.13.3 Beijing Tide Pharmaceutical Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.14 Mundipharma
 3.14.1 Mundipharma Company Profile
 3.14.2 Mundipharma Transdermal Patch Product Specification
 3.14.3 Mundipharma Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.15 Dr Reddy’s Laboratories
 3.15.1 Dr Reddy’s Laboratories Company Profile
 3.15.2 Dr Reddy’s Laboratories Transdermal Patch Product Specification
 3.15.3 Dr Reddy’s Laboratories Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.16 Bayer
 3.16.1 Bayer Company Profile
 3.16.2 Bayer Transdermal Patch Product Specification
 3.16.3 Bayer Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 4 Global Transdermal Patch Market Competition by Market Players
 4.1 Global Transdermal Patch Production Capacity Market Share by Market Players (2016-2021)
 4.2 Global Transdermal Patch Revenue Market Share by Market Players (2016-2021)
 4.3 Global Transdermal Patch Average Price by Market Players (2016-2021)
 5 Global Transdermal Patch Production by Regions (2016-2021)
 5.1 North America
 5.1.1 North America Transdermal Patch Market Size (2016-2021)
 5.1.2 Transdermal Patch Key Players in North America (2016-2021)
 5.1.3 North America Transdermal Patch Market Size by Type (2016-2021)
 5.1.4 North America Transdermal Patch Market Size by Application (2016-2021)
 5.2 East Asia
 5.2.1 East Asia Transdermal Patch Market Size (2016-2021)
 5.2.2 Transdermal Patch Key Players in East Asia (2016-2021)
 5.2.3 East Asia Transdermal Patch Market Size by Type (2016-2021)
 5.2.4 East Asia Transdermal Patch Market Size by Application (2016-2021)
 5.3 Europe
 5.3.1 Europe Transdermal Patch Market Size (2016-2021)
 5.3.2 Transdermal Patch Key Players in Europe (2016-2021)
 5.3.3 Europe Transdermal Patch Market Size by Type (2016-2021)
 5.3.4 Europe Transdermal Patch Market Size by Application (2016-2021)
 5.4 South Asia
 5.4.1 South Asia Transdermal Patch Market Size (2016-2021)
 5.4.2 Transdermal Patch Key Players in South Asia (2016-2021)
 5.4.3 South Asia Transdermal Patch Market Size by Type (2016-2021)
 5.4.4 South Asia Transdermal Patch Market Size by Application (2016-2021)
 5.5 Southeast Asia
 5.5.1 Southeast Asia Transdermal Patch Market Size (2016-2021)
 5.5.2 Transdermal Patch Key Players in Southeast Asia (2016-2021)
 5.5.3 Southeast Asia Transdermal Patch Market Size by Type (2016-2021)
 5.5.4 Southeast Asia Transdermal Patch Market Size by Application (2016-2021)
 5.6 Middle East
 5.6.1 Middle East Transdermal Patch Market Size (2016-2021)
 5.6.2 Transdermal Patch Key Players in Middle East (2016-2021)
 5.6.3 Middle East Transdermal Patch Market Size by Type (2016-2021)
 5.6.4 Middle East Transdermal Patch Market Size by Application (2016-2021)
 5.7 Africa
 5.7.1 Africa Transdermal Patch Market Size (2016-2021)
 5.7.2 Transdermal Patch Key Players in Africa (2016-2021)
 5.7.3 Africa Transdermal Patch Market Size by Type (2016-2021)
 5.7.4 Africa Transdermal Patch Market Size by Application (2016-2021)
 5.8 Oceania
 5.8.1 Oceania Transdermal Patch Market Size (2016-2021)
 5.8.2 Transdermal Patch Key Players in Oceania (2016-2021)
 5.8.3 Oceania Transdermal Patch Market Size by Type (2016-2021)
 5.8.4 Oceania Transdermal Patch Market Size by Application (2016-2021)
 5.9 South America
 5.9.1 South America Transdermal Patch Market Size (2016-2021)
 5.9.2 Transdermal Patch Key Players in South America (2016-2021)
 5.9.3 South America Transdermal Patch Market Size by Type (2016-2021)
 5.9.4 South America Transdermal Patch Market Size by Application (2016-2021)
 5.10 Rest of the World
 5.10.1 Rest of the World Transdermal Patch Market Size (2016-2021)
 5.10.2 Transdermal Patch Key Players in Rest of the World (2016-2021)
 5.10.3 Rest of the World Transdermal Patch Market Size by Type (2016-2021)
 5.10.4 Rest of the World Transdermal Patch Market Size by Application (2016-2021)
 6 Global Transdermal Patch Consumption by Region (2016-2021)
 6.1 North America
 6.1.1 North America Transdermal Patch Consumption by Countries
 6.1.2 United States
 6.1.3 Canada
 6.1.4 Mexico
 6.2 East Asia
 6.2.1 East Asia Transdermal Patch Consumption by Countries
 6.2.2 China
 6.2.3 Japan
 6.2.4 South Korea
 6.3 Europe
 6.3.1 Europe Transdermal Patch Consumption by Countries
 6.3.2 Germany
 6.3.3 United Kingdom
 6.3.4 France
 6.3.5 Italy
 6.3.6 Russia
 6.3.7 Spain
 6.3.8 Netherlands
 6.3.9 Switzerland
 6.3.10 Poland
 6.4 South Asia
 6.4.1 South Asia Transdermal Patch Consumption by Countries
 6.4.2 India
 6.5 Southeast Asia
 6.5.1 Southeast Asia Transdermal Patch Consumption by Countries
 6.5.2 Indonesia
 6.5.3 Thailand
 6.5.4 Singapore
 6.5.5 Malaysia
 6.5.6 Philippines
 6.6 Middle East
 6.6.1 Middle East Transdermal Patch Consumption by Countries
 6.6.2 Turkey
 6.6.3 Saudi Arabia
 6.6.4 Iran
 6.6.5 United Arab Emirates
 6.7 Africa
 6.7.1 Africa Transdermal Patch Consumption by Countries
 6.7.2 Nigeria
 6.7.3 South Africa
 6.8 Oceania
 6.8.1 Oceania Transdermal Patch Consumption by Countries
 6.8.2 Australia
 6.9 South America
 6.9.1 South America Transdermal Patch Consumption by Countries
 6.9.2 Brazil
 6.9.3 Argentina
 6.10 Rest of the World
 6.10.1 Rest of the World Transdermal Patch Consumption by Countries
 7 Global Transdermal Patch Production Forecast by Regions (2022-2027)
 7.1 Global Forecasted Production of Transdermal Patch (2022-2027)
 7.2 Global Forecasted Revenue of Transdermal Patch (2022-2027)
 7.3 Global Forecasted Price of Transdermal Patch (2022-2027)
 7.4 Global Forecasted Production of Transdermal Patch by Region (2022-2027)
 7.4.1 North America Transdermal Patch Production, Revenue Forecast (2022-2027)
 7.4.2 East Asia Transdermal Patch Production, Revenue Forecast (2022-2027)
 7.4.3 Europe Transdermal Patch Production, Revenue Forecast (2022-2027)
 7.4.4 South Asia Transdermal Patch Production, Revenue Forecast (2022-2027)
 7.4.5 Southeast Asia Transdermal Patch Production, Revenue Forecast (2022-2027)
 7.4.6 Middle East Transdermal Patch Production, Revenue Forecast (2022-2027)
 7.4.7 Africa Transdermal Patch Production, Revenue Forecast (2022-2027)
 7.4.8 Oceania Transdermal Patch Production, Revenue Forecast (2022-2027)
 7.4.9 South America Transdermal Patch Production, Revenue Forecast (2022-2027)
 7.4.10 Rest of the World Transdermal Patch Production, Revenue Forecast (2022-2027)
 7.5 Forecast by Type and by Application (2022-2027)
 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
 7.5.2 Global Forecasted Consumption of Transdermal Patch by Application (2022-2027)
 8 Global Transdermal Patch Consumption Forecast by Regions (2022-2027)
 8.1 North America Forecasted Consumption of Transdermal Patch by Country
 8.2 East Asia Market Forecasted Consumption of Transdermal Patch by Country
 8.3 Europe Market Forecasted Consumption of Transdermal Patch by Countriy
 8.4 South Asia Forecasted Consumption of Transdermal Patch by Country
 8.5 Southeast Asia Forecasted Consumption of Transdermal Patch by Country
 8.6 Middle East Forecasted Consumption of Transdermal Patch by Country
 8.7 Africa Forecasted Consumption of Transdermal Patch by Country
 8.8 Oceania Forecasted Consumption of Transdermal Patch by Country
 8.9 South America Forecasted Consumption of Transdermal Patch by Country
 8.10 Rest of the world Forecasted Consumption of Transdermal Patch by Country
 9 Global Transdermal Patch Sales by Type (2016-2027)
 9.1 Global Transdermal Patch Historic Market Size by Type (2016-2021)
 9.2 Global Transdermal Patch Forecasted Market Size by Type (2022-2027)
 10 Global Transdermal Patch Consumption by Application (2016-2027)
 10.1 Global Transdermal Patch Historic Market Size by Application (2016-2021)
 10.2 Global Transdermal Patch Forecasted Market Size by Application (2022-2027)
 11 Global Transdermal Patch Manufacturing Cost Analysis
 11.1 Transdermal Patch Key Raw Materials Analysis
 11.1.1 Key Raw Materials
 11.2 Proportion of Manufacturing Cost Structure
 11.3 Manufacturing Process Analysis of Transdermal Patch
 12 Global Transdermal Patch Marketing Channel, Distributors, Customers and Supply Chain
 12.1 Marketing Channel
 12.2 Transdermal Patch Distributors List
 12.3 Transdermal Patch Customers
 12.4 Transdermal Patch Supply Chain Analysis
 13 Analyst's Viewpoints/Conclusions
 14 Disclaimer

Add to Cart

Single User

$ 2450.00

Site License

$ 3675.00

Enterprisewide

$ 4900.00